Correlation Between Inhibikase Therapeutics and NGM Biopharmaceutica
Can any of the company-specific risk be diversified away by investing in both Inhibikase Therapeutics and NGM Biopharmaceutica at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Inhibikase Therapeutics and NGM Biopharmaceutica into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Inhibikase Therapeutics and NGM Biopharmaceuticals, you can compare the effects of market volatilities on Inhibikase Therapeutics and NGM Biopharmaceutica and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Inhibikase Therapeutics with a short position of NGM Biopharmaceutica. Check out your portfolio center. Please also check ongoing floating volatility patterns of Inhibikase Therapeutics and NGM Biopharmaceutica.
Diversification Opportunities for Inhibikase Therapeutics and NGM Biopharmaceutica
-0.63 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Inhibikase and NGM is -0.63. Overlapping area represents the amount of risk that can be diversified away by holding Inhibikase Therapeutics and NGM Biopharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on NGM Biopharmaceuticals and Inhibikase Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Inhibikase Therapeutics are associated (or correlated) with NGM Biopharmaceutica. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of NGM Biopharmaceuticals has no effect on the direction of Inhibikase Therapeutics i.e., Inhibikase Therapeutics and NGM Biopharmaceutica go up and down completely randomly.
Pair Corralation between Inhibikase Therapeutics and NGM Biopharmaceutica
If you would invest 228.00 in Inhibikase Therapeutics on September 12, 2024 and sell it today you would earn a total of 92.00 from holding Inhibikase Therapeutics or generate 40.35% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Weak |
Accuracy | 0.3% |
Values | Daily Returns |
Inhibikase Therapeutics vs. NGM Biopharmaceuticals
Performance |
Timeline |
Inhibikase Therapeutics |
NGM Biopharmaceuticals |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Inhibikase Therapeutics and NGM Biopharmaceutica Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Inhibikase Therapeutics and NGM Biopharmaceutica
The main advantage of trading using opposite Inhibikase Therapeutics and NGM Biopharmaceutica positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Inhibikase Therapeutics position performs unexpectedly, NGM Biopharmaceutica can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in NGM Biopharmaceutica will offset losses from the drop in NGM Biopharmaceutica's long position.Inhibikase Therapeutics vs. Equillium | Inhibikase Therapeutics vs. DiaMedica Therapeutics | Inhibikase Therapeutics vs. Valneva SE ADR | Inhibikase Therapeutics vs. Vivani Medical |
NGM Biopharmaceutica vs. Instil Bio | NGM Biopharmaceutica vs. Achilles Therapeutics PLC | NGM Biopharmaceutica vs. NextCure | NGM Biopharmaceutica vs. Assembly Biosciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Other Complementary Tools
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
Commodity Directory Find actively traded commodities issued by global exchanges |